PubMed Journals Articles About "Long Term Outcomes With Boston Type Keratoprosthesis Ocular" RSS

13:35 EDT 24th March 2019 | BioPortfolio

Long Term Outcomes With Boston Type Keratoprosthesis Ocular PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Long Term Outcomes With Boston Type Keratoprosthesis Ocular articles that have been published worldwide.

More Information about "Long Term Outcomes With Boston Type Keratoprosthesis Ocular" on BioPortfolio

We have published hundreds of Long Term Outcomes With Boston Type Keratoprosthesis Ocular news stories on BioPortfolio along with dozens of Long Term Outcomes With Boston Type Keratoprosthesis Ocular Clinical Trials and PubMed Articles about Long Term Outcomes With Boston Type Keratoprosthesis Ocular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Long Term Outcomes With Boston Type Keratoprosthesis Ocular Companies in our database. You can also find out about relevant Long Term Outcomes With Boston Type Keratoprosthesis Ocular Drugs and Medications on this site too.

Showing "Long term outcomes with Boston type keratoprosthesis ocular" PubMed Articles 1–25 of 25,000+

Boston type I keratoprosthesis implantation technique : Video article.

Keratoprosthetics refer to the replacement of human corneal tissue with an artificially produced exchange product. The most widely implanted keratoprosthesis worldwide is the Boston Type I Keratoprosthesis (BI-KPro, Massachusetts Eye and Ear Infirmary, Boston, MA, USA).

Boston Type 2 keratoprosthesis- mid term outcomes from a tertiary eye care centre in India.

To analyse the anatomical and functionaloutcomes of Boston type II keratoprosthesis at a tertiary eye care centre in South India. Retrospective chart review of 10 patients operated with Boston keratoprosthesis Type 2 between Feb 2013 and June 2017 were analysed. Outcome measures analysed included, visual outcome, device retention and postoperative complications. The most common indication for surgery was SJS in 80% (8 of 10 eyes). Mean follow-up duration was 2.75 years (0.5-5 years, SD - 1.71, median 32...

Staged ocular fornix reconstruction for glaucoma drainage device under neoconjunctiva at the time of Boston type 1 Keratoprosthesis implantation.

Glaucoma is the leading cause of vision loss in eyes with Boston Keratoprosthesis (KPro). Glaucoma drainage devices (GDDs) have been shown to be effective in controlling glaucoma with KPro. Cicatricial conjunctival disease with forniceal shortening is a major challenge and limitation to the use of GDD. In our series, we report the success of fornix reconstruction in cicatricial ocular surface disease as a staged procedure prior to a combined KPro/GDD surgery.

Comparative Outcomes of Boston Keratoprosthesis Type 1 Implantation Based on Vision in the Contralateral Eye.

To compare the outcomes of Boston keratoprosthesis type 1 implantation after failed keratoplasty in patients who are blind or sighted in the contralateral eye.

Telemetric Intraocular Pressure Monitoring after Boston Keratoprosthesis surgery with the Eyemate-IO Sensor: Dynamics in the first year.

To analyse the dynamics of telemetrically measured intraocular pressure (IOP) during year one after implantation of a Boston Keratoprosthesis Type I (BI-KPro) and to compare agreement of telemetric IOP measurements with finger palpation.

Intraocular Light Scatter in Eyes With the Boston Type 1 Keratoprosthesis.

The Boston keratoprosthesis (KPro) is the most commonly used artificial cornea. It has been proven to be successful for severe corneal disease not amenable to keratoplasty. We have observed our patients reporting debilitating glare despite attaining good visual acuities. This motivated us to objectively measure light scatter in eyes with a KPro.

Outcomes of the Boston Type I Keratoprosthesis as the Primary Penetrating Corneal Procedure.

To report the outcomes of the Boston type I keratoprosthesis (KPro) as the primary penetrating corneal procedure.

Antibiotic Resistance Induction in Eyes With Boston Type I Keratoprosthesis.

Boston Type I Keratoprosthesis: Antibacterial Resistance and Microbiota Evaluation of Soft Contact Lenses.

A Long-term Safety Study of Latanoprost in Pediatric Patients with Glaucoma and Ocular Hypertension: A Prospective Cohort Study.

The objective was to assess the long-term effect of treatment with latanoprost on ocular development and safety in pediatric patients with glaucoma and ocular hypertension.

Development and Long-Term Evaluation of Ocular Surface Conditions Using Ovariectomized Cynomolgus Monkey.

We aim to use the ovariectomized cynomolgus monkey to observe the effect of long-term changes of sex hormone levels on ocular surface.


This institutional study sought to retrospectively evaluate disease progression and survival of patients with differentiated thyroid cancer (DTC) and bone metastases (BM) and to investigate variables predictive of better long-term outcomes.

Long-term (8.5 years) analysis of the type and rate of reoperation after transvaginal mesh repair (Prolift) in 349 patients.

Polypropylene meshes have specific complications, and in 2016 the Food and Drug Administration required a Premarket Approval for their use in pelvic prolapse repair, as there was a lack of long-term data. Our objectives were to determine the long-term reoperation rates and type in our patients after transvaginal mesh repair and to study their risk factors.

Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization.

To report the long-term outcome of Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) for delivery of bevacizumab in the treatment of corneal neovascularization (KNV).


To determine long-term visual outcomes in patients who developed endophthalmitis after intravitreal anti-vascular endothelial growth factor injections and to correlate visual outcomes with clinical features.

Long-Term Follow-up of Spasmus Nutans.

Spasmus nutans is an acquired form of nystagmus that is classically associated with torticollis and titubations of the head, often presenting in the first year of life and spontaneously resolving within the next 2 years. The purpose of our study was to record and characterize the long-term prognosis of children diagnosed with spasmus nutans.

Molecular Epidemiological Analysis of the Spreading Conditions of Trichophyton  in the Long-term Care Facilities in Japan.

Tinea pedis and Tinea unguium are the common infectious disease, and it is reported a lot of the elderly people develop these infections. In this study, in order to investigate whether strains from the same type origin are spreading inside the long-term care facility or not, we analyzed Trichophyton rubrum and Trichophyton mentagrophytes isolated from the residents and the staff at the facilities located in Kanto area, using a genomic analytical method targeting tandem repeat regions in the non-transcribed ...

Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution.

Evaluate netarsudil 0.02% ophthalmic solution in patients with open-angle glaucoma (OAG) and ocular hypertension (OHT). Design; Double-masked, randomized, multi-center, parallel-group, non-inferiority clinical study.

Piezoelectric harvest of osteo-odonto-lamina in modified osteo-odonto keratoprosthesis: A maxillofacial perspective.

We describe the piezo-osteotomy feasibility in rehabilitation and harvesting of osteo-odonto lamina in modified osteo-odonto keratoprosthesis (MOOKP) surgery. Surgery was evaluated regarding operative technique and success of the keratoprosthesis (KPros) in terms of perception to light (+ve) to finger counting (+ve).

Effect of long-term sodium nitrate administration on diabetes-induced anemia and glucose homeostasis in obese type 2 diabetic male rats.

Anemia is common in patients with type 2 diabetes. This aims at determining long-term effects of nitrate administration on diabetes-induced anemia in obese type 2 diabetic rats.


To identify risk factors for fixation failure, report patient outcomes and advise on modifications to the surgical technique for fibula nail stabilisation of unstable ankle fractures.

Treatment of Intermittent Exotropia of the Convergence Insufficiency Type with Bupivacaine 0.75%: 5-Year Experience and Outcomes.

Bupivicaine has been shown to stimulate ocular muscle structure and length after injection into ocular muscles. Bupivicaine 0.75% has been utilized in the treatment of strabismus to alter ocular alignment by strengthening an ocular muscle. This study is designed to report 5-year follow-up outcomes after bupivicaine injection.

Bony Decompression for Chiari Malformation Type I: Long-Term Follow-Up.

Several surgical techniques are used for the management of Chiari malformation type I (CM-I). Bony posterior fossa decompression is considered a good option in children, though with a higher risk of requiring reoperation. However, there is not enough evidence from the series in the literature, which are often limited by inadequate follow-up. The goal of this study was to assess the effectiveness of suboccipital craniectomy alone in children after long-term follow-up.

Eleven Years of Cataract Surgery in Veterans Without Pre-existing Ocular Comorbidities.

In 2017, over 75,000 cataract surgeries were performed within the Veterans Health Administration System (VHA). Previous reports of outcomes of cataract surgery in veterans include patients with pre-existing ocular disease, which can affect vision. To exclude the confounding factor of pre-existing ocular comorbidities, we investigated the long-term visual outcomes and complications associated with small incision cataract surgery performed on veterans without any pre-existing eye disease.

Ocular dysfunctions and toxicities induced by antiepileptic medications: Types, pathogenic mechanisms and treatment strategies.

Ocular dysfunctions and toxicities induced by antiepileptic drugs (AEDs) are rarely reviewed and not frequently received attention by treating physicians compared to other adverse effects (e.g. endocrinologic, cognitive and metabolic). However, some are frequent and progressive even in therapeutic concentrations or result in permanent blindness. Although, some adverse effects are non-specific, others are related to the specific pharmacodynamics of the drug. Areas covered: This review was written after detai...

Quick Search